Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol

« Previous Article | Table of Contents | Next Article »

Arteriosclerosis, Thrombosis, and Vascular Biology. 1992;12:671-674

This Article

	Full Text (PDF)
	Submit a response
	Alert me when this article is cited
	Alert me when eLetters are posted
	Alert me if a correction is posted
	Citation Map

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager
	Request Permissions

Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Auwerx, J.
	Articles by Kesteloot, H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Auwerx, J.
	Articles by Kesteloot, H.

ARTICLES

Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol

J Auwerx, R Bouillon and H Kesteloot
Department of Developmental Biology, University of Leuven Medical School, Belgium.

In a survey of cardiovascular risk factors in 185 men and 173 women of a Belgian population group, an independent and highly significant positive correlation was found between the serum concentrations of 25- hydroxyvitamin D3 and apolipoprotein A-I (p less than 0.001 in both sexes). 25-Hydroxyvitamin D3 also showed a positive correlation with high density lipoprotein cholesterol levels (p less than 0.05 in men and p less than 0.005 in women). This relation was independent of a possible effect of 25-hydroxyvitamin D3 on serum calcium. Taking the biological variation of 25-hydroxyvitamin D3 levels (+/- 2 SD = 25 ng/ml) into account, these findings could explain variations in the levels of apolipoprotein A-I of 15 mg/100 ml and of high density lipoprotein cholesterol of 4 mg/100 ml.

This article has been cited by other articles:

J. Kumar, P. Muntner, F. J. Kaskel, S. M. Hailpern, and M. L. Melamed
Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001-2004
Pediatrics, September 1, 2009; 124(3): e362 - e370.
[Abstract] [Full Text] [PDF]

E. Hypponen, B. J. Boucher, D. J. Berry, and C. Power
25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age: A Cross-Sectional Study in the 1958 British Birth Cohort
Diabetes, February 1, 2008; 57(2): 298 - 305.
[Abstract] [Full Text] [PDF]

G. M. London, A. P. Guerin, F. H. Verbeke, B. Pannier, P. Boutouyrie, S. J. Marchais, and F. Metivier
Mineral Metabolism and Arterial Functions in End-Stage Renal Disease: Potential Role of 25-Hydroxyvitamin D Deficiency
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 613 - 620.
[Abstract] [Full Text] [PDF]

G. C Major, F. Alarie, J. Dore, S. Phouttama, and A. Tremblay
Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 54 - 59.
[Abstract] [Full Text] [PDF]

A. D. Mooradian, M. J. Haas, and N. C. W. Wong
The Effect of Select Nutrients on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels
Endocr. Rev., February 1, 2006; 27(1): 2 - 16.
[Abstract] [Full Text] [PDF]

W G. John, K. Noonan, N. Mannan, and B. J Boucher
Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis
Am. J. Clinical Nutrition, September 1, 2005; 82(3): 517 - 522.
[Abstract] [Full Text] [PDF]

U. QUERFELD, M. M. HOFFMANN, G. KLAUS, F. EIFINGER, M. ACKERSCHOTT, D. MICHALK, and P. A. KERN
Antagonistic Effects of Vitamin D and Parathyroid Hormone on Lipoprotein Lipase in Cultured Adipocytes
J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2158 - 2164.
[Abstract] [Full Text]

				E. Hypponen, B. J. Boucher, D. J. Berry, and C. Power 25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age: A Cross-Sectional Study in the 1958 British Birth Cohort Diabetes, February 1, 2008; 57(2): 298 - 305. [Abstract] [Full Text] [PDF]

				G. M. London, A. P. Guerin, F. H. Verbeke, B. Pannier, P. Boutouyrie, S. J. Marchais, and F. Metivier Mineral Metabolism and Arterial Functions in End-Stage Renal Disease: Potential Role of 25-Hydroxyvitamin D Deficiency J. Am. Soc. Nephrol., February 1, 2007; 18(2): 613 - 620. [Abstract] [Full Text] [PDF]

				G. C Major, F. Alarie, J. Dore, S. Phouttama, and A. Tremblay Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations Am. J. Clinical Nutrition, January 1, 2007; 85(1): 54 - 59. [Abstract] [Full Text] [PDF]

				A. D. Mooradian, M. J. Haas, and N. C. W. Wong The Effect of Select Nutrients on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels Endocr. Rev., February 1, 2006; 27(1): 2 - 16. [Abstract] [Full Text] [PDF]

				W G. John, K. Noonan, N. Mannan, and B. J Boucher Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis Am. J. Clinical Nutrition, September 1, 2005; 82(3): 517 - 522. [Abstract] [Full Text] [PDF]

				U. QUERFELD, M. M. HOFFMANN, G. KLAUS, F. EIFINGER, M. ACKERSCHOTT, D. MICHALK, and P. A. KERN Antagonistic Effects of Vitamin D and Parathyroid Hormone on Lipoprotein Lipase in Cultured Adipocytes J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2158 - 2164. [Abstract] [Full Text]